<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00121 Mid Day Module (Pyqs, Mixed Bag-18) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">40</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 57692,
    "choices": [
      {
        "id": 230137,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B6</span></span></span></p>"
      },
      {
        "id": 230138,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B12</span></span></span></p>"
      },
      {
        "id": 230139,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thiamine</span></span></span></p>"
      },
      {
        "id": 230140,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B2</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient has mental retardation, seizures, thrombotic state, amino acid metabolism disorder, osteoporosis, and ectopia lentis. Which vitamin must be supplemented to the patient? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q4938291",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507160,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Vitamin B6</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation, including mental retardation, seizures, a thrombotic state, osteoporosis, and ectopia lentis, is characteristic of <strong>homocystinuria</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Homocystinuria is a genetic disorder caused by a deficiency of cystathionine beta-synthase (CBS), an enzyme involved in methionine metabolism. This deficiency leads to an accumulation of homocysteine, which can cause a wide range of symptoms, including neurodevelopmental issues, skeletal abnormalities, and vascular complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B6 (pyridoxine) is crucial in the management of homocystinuria, as it is a cofactor for CBS. Supplementation with vitamin B6 can enhance the activity of the residual enzyme, helping to reduce homocysteine levels in responsive patients, thus mitigating the symptoms and reducing the risk of complications such as thrombosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note </span></strong><span style=\"font-size:12.0pt\">&ndash; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The causes of <strong>ectopia lentis</strong> include several conditions, such as <strong>Marfan&#39;s syndrome</strong>, <strong>homocystinuria</strong>, <strong>Weill-Marchesani syndrome</strong>, and <strong>Ehlers-Danlos syndrome</strong>. These are important to remember when identifying the underlying cause of lens dislocation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Vitamin B12:</span></strong><span style=\"font-size:12.0pt\"> While vitamin B12 is also involved in homocysteine metabolism, deficiencies in B12 are not directly related to the presentation seen in homocystinuria. B12 supplementation is more relevant to other conditions such as pernicious anemia or when correcting elevated homocysteine due to B12 deficiency, but it is not the primary treatment for homocystinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Thiamine:</span></strong><span style=\"font-size:12.0pt\"> Thiamine (vitamin B1) is not involved in the metabolic pathway of homocysteine. It plays a role in carbohydrate metabolism and is associated with conditions like Wernicke-Korsakoff syndrome and beriberi but not with homocystinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vitamin B2:</span></strong><span style=\"font-size:12.0pt\"> Riboflavin (vitamin B2) is not directly related to the symptoms of homocystinuria or the management of this disorder. It is mainly involved in energy production and the metabolism of fats, drugs, and steroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homocystinuria is characterized by ectopia lentis, thrombotic state, mental retardation, and seizures, among other features. Vitamin B6 supplementation is essential in managing this condition by aiding the function of the deficient enzyme cystathionine beta-synthase.</span></span></p>",
    "correct_choice_id": 230137,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4550,
    "choices": [
      {
        "id": 18176,
        "text": "<p><span style=\"font-size:12pt;\">Mutation</span></p>"
      },
      {
        "id": 18177,
        "text": "<p><span style=\"font-size:12pt;\">Epigenetics</span></p>"
      },
      {
        "id": 18178,
        "text": "<p><span style=\"font-size:12pt;\">Translocation</span></p>"
      },
      {
        "id": 18179,
        "text": "<p><span style=\"font-size:12pt;\">Inversion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following can alter the gene expression by methylation and acetylation but not change the gene sequence?&nbsp;</span>(NEET PG 2018)</p>",
    "unique_key": "Q8740019",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507153,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Epigenetics</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Epigenetics refers to the study of heritable changes in gene expression or cellular phenotype that do not involve alterations to the underlying DNA sequence. Epigenetic mechanisms, such as DNA methylation and histone acetylation, can modify gene expression by adding or removing chemical marks on DNA or histone proteins, thereby influencing how genes are activated or silenced. These changes can be passed from one generation of cells to the next, making them heritable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mutation: </strong>Mutations are changes in the DNA sequence itself. They can result in alterations to the genetic code, potentially leading to changes in gene expression. Mutations are genetic changes and do not fall under the category of epigenetic modifications, which involve changes to gene expression without altering the underlying DNA sequence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Translocation: </strong>Translocation involves the rearrangement of genetic material between non-homologous chromosomes. It can lead to changes in gene positioning but is not primarily associated with epigenetic modifications like methylation and acetylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Inversion: </strong>Inversion is a type of chromosomal rearrangement where a segment of a chromosome is reversed. Similar to translocation, it can result in changes in gene positioning but is not directly related to epigenetic modifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Epigenetics has been defined and today is generally accepted as \u2018\u2018<strong>the study of changes in gene function that are mitotically and/or meiotically heritable and that do not entail a change in DNA sequence.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Epigenetic modification of core histones (acetylation of specific lysine residues) facilitates an open structure and permits access to transcription factors for interaction with DNA. On the other hand, methylation at the CG sequence of the promoters transcriptionally inactivates chromatin.</span></p>",
    "correct_choice_id": 18177,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55427,
    "choices": [
      {
        "id": 221169,
        "text": "<p><span style=\"font-size:12.0pt;\">DOTS</span></p>"
      },
      {
        "id": 221170,
        "text": "<p><span style=\"font-size:12.0pt;\">DOTS-99</span></p>"
      },
      {
        "id": 221171,
        "text": "<p><span style=\"font-size:12.0pt;\">Nikshay</span></p>"
      },
      {
        "id": 221172,
        "text": "<p><span style=\"font-size:12.0pt;\">Nischay</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the Information Communication Technology based Surveillance system for TB patients under National TB Elimination Program? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q6769280",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507166,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nikshay</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nikshay is an online software platform used in India for the surveillance of tuberculosis (TB) patients under the National TB Elimination Program. This Information and Communication Technology (ICT)-based system connects all the DOTS (Directly Observed Treatment, Short-course) clinics across the country to a central server managed by the Ministry of Health and Family Welfare. It allows for real-time data generation and monitoring, providing critical insights into cure rates, incidences of multi-drug-resistant TB (MDR-TB), treatment failures, relapses, and other important metrics. The system's comprehensive data collection capabilities make it an essential tool in the fight against TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. DOTS</strong>:<strong> </strong>DOTS (Directly Observed Treatment, Short-course) is a strategy rather than a surveillance system. It involves healthcare workers observing patients take their TB medication to ensure compliance, but it is not a technological platform like Nikshay.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DOTS-99</strong>:<strong> </strong>DOTS-99 is an ICT-based adherence system, not a surveillance system. It is designed to ensure patients adhere to their TB treatment regimen. After taking their medication, patients give a missed call to a toll-free number using their registered mobile number. This system is effective in tracking medication adherence but does not provide the comprehensive surveillance and data management features of Nikshay.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nischay</strong>:<strong> </strong>\"Nischay\" is not related to TB surveillance or management. This option does not pertain to any ICT-based system for TB patients under the National TB Elimination Program.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nikshay</strong> is the ICT-based surveillance system used for TB patients under the National TB Elimination Program in India. It enables real-time data collection and monitoring of TB cases across the country.</span></p>",
    "correct_choice_id": 221171,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14918,
    "choices": [
      {
        "id": 59632,
        "text": "<p><span style=\"font-size:12.0pt;\">Reapply cast</span></p>"
      },
      {
        "id": 59633,
        "text": "<p><span style=\"font-size:12.0pt;\">Get a venous Doppler done</span></p>"
      },
      {
        "id": 59634,
        "text": "<p><span style=\"font-size:12.0pt;\">Measure anterior compartment pressure</span></p>"
      },
      {
        "id": 59635,
        "text": "<p><span style=\"font-size:12.0pt;\">Give analgesics</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient suffered from tibial fracture following a road traffic accident. He complained of pain on passive flexion. His posterior tibial and dorsalis pedis pulses were palpable, but he had loss of sensation in the 1st webspace. What will be the next step? (INICET NOV 2021)</span></p>",
    "unique_key": "Q3994046",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507159,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Measure anterior compartment pressure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>COMPARTMENT SYNDROME</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In acute compartment syndrome, <strong>increased pressure in a close fascial space</strong> causes loss of microcirculation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Most commonly</strong> compartment syndrome involves <strong>deep posterior compartment of leg &gt; deep flexor compartment of forearm</strong> <strong>(commonest in children).</strong></span></li><li><span style=\"font-size:12.0pt;\">It is most commonly seen following fractures of supracondylar humerus and tibia.</span></li><li><span style=\"font-size:12.0pt;\">Most common cause is fractures and dislocations.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other causes of compartment syndrome are:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Crush injury/Burn/Infection/Surgical procedure/Tight circumferential dressing</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exercise</strong>: Exercise may increase intracompartmental pressure and muscle edema, so it is avoided in cases of acute compartmental syndrome.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">The diagnosis is based on dramatically increasing pain (out of proportion to injury) after fracture/any injury (1st symptom) not even getting relieved on analgesics.</span></li><li><span style=\"font-size:12.0pt;\">Pain and resistance on passive stretch (Distal most joint of extremity) \u2013 <strong>1st sign</strong></span></li><li><span style=\"font-size:12.0pt;\">Order of compression of vascular structures with increase of intracompartmental pressure is: capillary compression, venous compression, arterial compression.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pulselessness is a late feature</strong> and it is not a reliable indicator of compartment syndrome.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The presence of pulse does not exclude the diagnosis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In later stages, paresthesia and paralysis ensue due to nerve involvement.</span></li><li><span style=\"font-size:12.0pt;\">Pressures in the deep volar compartment are significantly elevated compared with pressures in other compartments. <strong>Deep flexor muscles are involved particularly flexor digitorum profundus &gt; flexor pollicis longus</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Acute compartment syndrome presents with the following 5 Ps:</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-05-163810.jpg\" alt=\"\" width=\"1000\" height=\"370\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:&nbsp;</strong></span><ul><li><span style=\"font-size:12.0pt;\">The <strong>limb should be kept at the level of heart rather than elevated</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Removal of all circumferential dressing reduce pressure up to 85%.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fasciotomy</strong> is recommended in the presence of clinical signs of compartment syndrome, such as undue pain and a palpable firmness in the forearm. The morbidity caused by fasciotomy is minimal, whereas that caused by an untreated compartment syndrome is much greater.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>The general indications for fasciotomy are:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Impending tissue ischemia</span></li><li><span style=\"font-size:12.0pt;\">When the tissue pressure reaches 30 mm Hg or the difference between diastolic blood pressure and compartment pressure is less than 30 mm Hg (Normal compartment pressure is 8-10 mm Hg and pressure at calf during walking is 200-300 mm Hg).</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\">A higher pressure is a strong indication that fasciotomy should be recommended.</span></li><li><span style=\"font-size:12.0pt;\">In a hypotensive patient, the acceptable pressure is lower.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Extra Edge:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-105101.jpg\" alt=\"\" width=\"800\" height=\"287\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Reapply cast</strong>. Application of cast will further put pressure on the leg compartments. So, this treatment method will not help.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In this clinical scenario, the pain on passive flexion is the first sign of compartment syndrome. Pulselessness is the late feature. So it is advised to measure the compartment pressure first.</span></li></ul>",
    "correct_choice_id": 59634,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10203,
    "choices": [
      {
        "id": 40778,
        "text": "<p><span style=\"font-size:18px;\">Decision making</span></p>"
      },
      {
        "id": 40779,
        "text": "<p><span style=\"font-size:18px;\">Systems analysis</span></p>"
      },
      {
        "id": 40780,
        "text": "<p><span style=\"font-size:18px;\">Network analysis</span></p>"
      },
      {
        "id": 40781,
        "text": "<p><span style=\"font-size:18px;\">Management by objective</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which of these methods relies on behavioral sciences?</strong><i><strong> [NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q1850488",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507141,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Management by objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Management by objective (MBO) is a technique based on behavioral sciences. It was developed by Peter Drucker in the 1950s and emphasizes the importance of setting clear goals and objectives that are aligned with organizational goals, and then measuring progress towards achieving those objectives.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">MBO is based on the idea that individuals are motivated by the achievement of goals and that they perform better when they know what is expected of them. The technique involves a participatory process where employees are involved in setting their own goals and objectives, which are then reviewed and evaluated by their managers. This approach is intended to improve communication and collaboration within organizations, and to help employees feel more engaged and motivated in their work.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A</strong>. <strong>Decision making:</strong> &nbsp;This can rely on both behavioral sciences and quantitative methods, but in the context of management and organizational processes, it often involves analytical and quantitative approaches.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong> <strong>Systems analysis:&nbsp;</strong> This is a quantitative method used to understand and analyze complex systems and processes, often involving mathematical models and simulations.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong> <strong>Network analysis:&nbsp;</strong> This is a quantitative method used to plan and control complex projects, involving techniques like PERT (Program Evaluation and Review Technique) and CPM (Critical Path Method).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-150243.png\" alt=\"\" width=\"1000\" height=\"338\"></strong></span></p>",
    "correct_choice_id": 40781,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54291,
    "choices": [
      {
        "id": 216633,
        "text": "<p><span style=\"font-size:12.0pt;\">a, b</span></p>"
      },
      {
        "id": 216634,
        "text": "<p><span style=\"font-size:12.0pt;\">b, c</span></p>"
      },
      {
        "id": 216635,
        "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
      },
      {
        "id": 216636,
        "text": "<p><span style=\"font-size:12.0pt;\">Only b</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin is secreted by which of the following?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Liver</span><br><span style=\"font-size:12.0pt;\">b. Kidney</span><br><span style=\"font-size:12.0pt;\">c. Spleen</span><br><span style=\"font-size:12.0pt;\">d. Heart</span></p>",
    "unique_key": "Q5540668",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507152,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin (EPO) is a hormone responsible for stimulating the production of red blood cells in the bone marrow. The primary source of erythropoietin in the human body is the kidney, which accounts for about 90% of its production. The liver contributes approximately 10% of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Liver:</strong> The liver produces erythropoietin mainly during fetal development, and its contribution decreases postnatally, although it continues to produce a small amount in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Kidney:</strong> Erythropoietin is mainly produced by <strong>interstitial fibroblast-like cells located in the renal cortex, particularly near the proximal convoluted tubules.</strong> The production of EPO in the kidneys is primarily regulated by oxygen levels; hypoxia (low oxygen levels) stimulates its secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spleen and heart are not known sources of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option c &amp; d:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Neither the spleen nor the heart produce erythropoietin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin is primarily produced by the kidneys (90%) and to a lesser extent by the liver (10%). These organs are the main sources of erythropoietin in the human body, with the kidneys playing a dominant role in its regulation and production in response to hypoxia.</span></p>",
    "correct_choice_id": 216633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10206,
    "choices": [
      {
        "id": 40790,
        "text": "<p><span style=\"font-size:18px;\">Hypertriglyceridemia</span></p>"
      },
      {
        "id": 40791,
        "text": "<p><span style=\"font-size:18px;\">High LDL</span></p>"
      },
      {
        "id": 40792,
        "text": "<p><span style=\"font-size:18px;\">Central obesity</span></p>"
      },
      {
        "id": 40793,
        "text": "<p><span style=\"font-size:18px;\">Hypertension</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>According to NCEP-ATP III guidelines, which of the options below is not considered a criterion for metabolic syndrome?</strong><i><strong> [NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q3088207",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507164,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) High LDL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>High LDL:</strong> This is not a criterion for metabolic syndrome according to the NCEP-ATP III guidelines. While high LDL cholesterol is a significant risk factor for cardiovascular disease, it is not part of the metabolic syndrome criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Hypertriglyceridemia:</strong> Elevated triglyceride levels are a criterion for metabolic syndrome and indicate dyslipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong> <strong>Central Obesity:</strong> Defined by waist circumference, this is a key criterion for metabolic syndrome and indicates visceral fat accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Hypertension:</strong> Elevated blood pressure is included in the criteria for metabolic syndrome, reflecting its association with increased cardiovascular risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">According to NCEP-ATP III guidelines, criterion for metabolic syndromes are:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-150730.png\" alt=\"\" width=\"1000\" height=\"905\"></span></p>",
    "correct_choice_id": 40791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50172,
    "choices": [
      {
        "id": 200247,
        "text": "<p><span style=\"font-size:12.0pt;\">GM1</span></p>"
      },
      {
        "id": 200248,
        "text": "<p><span style=\"font-size:12.0pt;\">GM2</span></p>"
      },
      {
        "id": 200249,
        "text": "<p><span style=\"font-size:12.0pt;\">GM3</span></p>"
      },
      {
        "id": 200250,
        "text": "<p><span style=\"font-size:12.0pt;\">GM4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Vibrio cholerae binds with which receptors in the intestine? (</span>FMGE July 2023)</p>",
    "unique_key": "Q1278564",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507155,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) GM1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vibrio cholerae causes cholera, a disease characterized by severe watery diarrhea, often referred to as \"rice water stools.\" The pathogenesis of cholera involves the cholera toxin, which plays a critical role in the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Upon ingestion of contaminated food or water, Vibrio cholerae produces cholera toxin in the intestinal lumen. The cholera toxin (2 subunits \u2013 A &amp; B) does not enter the intestinal cells directly; instead, it binds to the GM1 ganglioside receptor on the surface of the intestinal epithelial cells. This binding facilitates the entry of the toxin into the cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Once inside the cell, the cholera toxin activates the enzyme adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP levels cause the inhibition of sodium absorption and an increase in chloride and water secretion into the intestinal lumen. This results in the characteristic watery diarrhea of cholera.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. GM2:</strong> This ganglioside receptor is not involved in the binding of cholera toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. GM3:</strong> This ganglioside receptor is not involved in the binding of cholera toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. GM4:</strong> This ganglioside receptor is not involved in the binding of cholera toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cholera toxin produced by Vibrio cholerae binds to the GM1 ganglioside receptor on the intestinal epithelial cells, leading to an increase in cyclic AMP and resulting in watery diarrhea.</span></p>",
    "correct_choice_id": 200247,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 56093,
    "choices": [
      {
        "id": 223797,
        "text": "<p><span style=\"font-size:12.0pt;\">Selective mutism</span></p>"
      },
      {
        "id": 223798,
        "text": "<p><span style=\"font-size:12.0pt;\">Conduct disorder</span></p>"
      },
      {
        "id": 223799,
        "text": "<p><span style=\"font-size:12.0pt;\">Binge eating disorder</span></p>"
      },
      {
        "id": 223800,
        "text": "<p><span style=\"font-size:12.0pt;\">Separation anxiety disorder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The persistence of ADHD in childhood increases the risk of development of which of the following in adolescence? (NEET PG 2024)</span></p>",
    "unique_key": "Q9487814",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507162,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Conduct disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Children with Attention-Deficit/Hyperactivity Disorder (ADHD) are at an increased risk of developing conduct disorder during adolescence. ADHD is characterized by impulsivity, hyperactivity, and inattention, which can lead to difficulty in following rules, controlling behavior, and maintaining social norms. When these symptoms persist into adolescence, they can manifest as more serious behavioral problems, such as conduct disorder, characterized by aggressive, antisocial, or defiant behaviors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conduct disorder is a common progression from ADHD because the underlying impulsivity and lack of self-control associated with ADHD often worsen over time, particularly when untreated. This progression underscores the importance of early intervention in managing ADHD symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - Children with ADHD are at risk of developing depression, antisocial personality disorder, substance use disorder, and conduct disorder <strong>as adults</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Selective mutism:</strong> This disorder involves a consistent failure to speak in specific social situations despite speaking in other situations, and it is more associated with anxiety disorders rather than ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Binge eating disorder:</strong> This condition involves recurrent episodes of eating large quantities of food, often quickly and to the point of discomfort. It is associated more with emotional regulation issues rather than impulsivity or behavioral problems typical of ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Separation anxiety disorder:</strong> This disorder is characterized by excessive fear or anxiety about separation from attachment figures. It is more commonly associated with anxiety disorders and does not have a direct link to ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The persistence of ADHD in childhood significantly increases the risk of developing conduct disorder during adolescence, highlighting the need for early and effective management of ADHD symptoms.</span></p>",
    "correct_choice_id": 223798,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52810,
    "choices": [
      {
        "id": 210729,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Whole Bowel Irrigation</span></span></span></p>"
      },
      {
        "id": 210730,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Activated charcoal</span></span></span></p>"
      },
      {
        "id": 210731,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dimercaprol</span></span></span></p>"
      },
      {
        "id": 210732,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Penicillamine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas revealed acidosis. Which of the following can be used in the management of this condition? (NEET PG 2023)</span></span></span></p>",
    "unique_key": "Q7478997",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507169,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Whole Bowel Irrigation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The child has ingested a significant amount of ferrous sulfate, leading to iron intoxication, which has resulted in metabolic acidosis. Managing iron overdose requires specific interventions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Iron Intoxication:</span></strong><span style=\"font-size:12.0pt\"> Iron overdose is a common pediatric poisoning that can lead to significant morbidity and mortality. Ingesting a large number of ferrous sulfate tablets can result in gastrointestinal irritation, systemic toxicity, and metabolic acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arterial Blood Gas (ABG) Revealed Acidosis:</span></strong><span style=\"font-size:12.0pt\"> Metabolic acidosis is a severe consequence of iron poisoning, indicating systemic toxicity.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Management of Iron Intoxication:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Whole Bowel Irrigation (WBI):</span></strong><span style=\"font-size:12.0pt\"> This is a key intervention for decontaminating the gastrointestinal tract in cases of iron overdose. WBI is performed using a polyethylene glycol-electrolyte solution to flush out the gastrointestinal contents. It is particularly useful <strong>when iron tablets are visible on an abdominal X-ray.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antidote:</span></strong><span style=\"font-size:12.0pt\"> The specific antidote for iron poisoning is deferoxamine, which binds free iron and promotes its excretion. While deferoxamine is essential in managing iron toxicity, it is not listed as an option in this question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Activated Charcoal:</span></strong><span style=\"font-size:12.0pt\"> As mentioned, it is not effective for iron, alcohols, acids, alkalis, or petroleum product intoxications. Activated charcoal does not adsorb iron, making it unsuitable for treating iron overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dimercaprol:</span></strong><span style=\"font-size:12.0pt\"> Used for heavy metal poisoning like arsenic, gold, and mercury, but not effective for iron.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Penicillamine:</span></strong><span style=\"font-size:12.0pt\"> Used primarily for heavy metal poisoning like copper and lead, and ineffective for iron.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Whole Bowel Irrigation with polyethylene glycol is the preferred method for managing iron tablet ingestion, especially when iron tablets are visible on an abdominal X-ray.</span></strong></span></span></p>",
    "correct_choice_id": 210729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5861,
    "choices": [
      {
        "id": 23414,
        "text": "<p><span style=\"font-size:12pt;\">Ovarian hyperstimulation syndrome</span></p>"
      },
      {
        "id": 23415,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffTheca lutein cyst</span></p>"
      },
      {
        "id": 23416,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffPolycystic ovarian syndrome</span></p>"
      },
      {
        "id": 23417,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffNone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A woman with a history of infertility is on treatment with human gonadotropin. She presented with the following finding in the USG. What is the most likely diagnosis?&nbsp;(</span>NEET PG 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture3.jpg\" alt=\"\" width=\"300\" height=\"160\"></span></p>",
    "unique_key": "Q6621601",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507137,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Ovarian hyperstimulation syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image is a transvaginal ultrasound showing the ovaries which appear significantly enlarged with fluid in the pelvic cavity (the black spaces seen in between the ovaries)</span></li><li><span style=\"font-size:12pt;\">In view of her history of controlled ovarian hyperstimulation in IVF, the answer is OHSS</span><ul><li><span style=\"font-size:12pt;\">Ovarian hyperstimulation syndrome is characterized by multiple ovarian follicular cysts accompanied by increased capillary permeability and leakage of intravascular fluid to the third space.</span></li><li><span style=\"font-size:12pt;\">It is commonly seen after exogenous administration of FSH, LH or HCG injections.</span></li><li><span style=\"font-size:12pt;\">Multiple enlarged follicles are arranged in a necklace pattern in bilateral ovaries.</span></li><li><span style=\"font-size:12pt;\">The mainstay of management is conservative. The ongoing stimulation cycle is suspended, and further administration of exogenous gonadotropins are stopped in that cycle.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Theca lutein cysts</strong>: Enlarged cysts seen in molar pregnancy, not related to the provided scenario or ultrasound findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Polycystic ovarian syndrome (PCOS)</strong>: PCOS is a risk factor for OHSS, but given the history and the ultrasound image, OHSS is the more appropriate answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">OHSS is characterized by multiple enlarged ovarian follicles and fluid accumulation in the pelvic cavity, often occurring after exogenous gonadotropin administration in infertility treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 456, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
    "correct_choice_id": 23414,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11616,
    "choices": [
      {
        "id": 46430,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce FiO2</span></span></span></p>"
      },
      {
        "id": 46431,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase tidal volume</span></span></span></p>"
      },
      {
        "id": 46432,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase respiratory rate</span></span></span></p>"
      },
      {
        "id": 46433,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase PEEP</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old female patient weighing 60 kg is on mechanical ventilation for ARDS secondary to urosepsis.&nbsp;</span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">The respiratory parameters are as follows: tidal volume- 360 mL; frequency- 30 breaths/min; PEEP- 5 cm of H2O; and FiO2- 90%.&nbsp;</span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arterial blood gas findings are as follows: paO2- 50 mmHg; paCO2- 38 mmHg and pH- 7.38.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the next step?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q4970510",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507161,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase PEEP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS) requires careful management of mechanical ventilation settings to optimize oxygenation while minimizing lung injury. The patient&#39;s current settings and blood gas findings suggest hypoxemia (paO2 of 50 mmHg) with an FiO2 of 90%. The goal in managing ARDS is to maintain adequate oxygenation (paO2 &gt; 60 mmHg) while reducing the FiO2 to less than 60% to avoid oxygen toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increasing PEEP is the best option to improve oxygenation. PEEP helps to keep alveoli open, improving gas exchange and oxygenation. By increasing PEEP, we can potentially increase the paO2 and eventually reduce the FiO2 to safer levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Reduce FiO2</strong>: Although reducing FiO2 is a long-term goal to prevent oxygen toxicity, it is not advisable to reduce it immediately because the patient is currently hypoxemic (paO2 of 50 mmHg).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase tidal volume</strong>: Not appropriate as it can increase the risk of ventilator-induced lung injury in ARDS patients. The current tidal volume is within the safe range (360 mL), which is appropriate for a 60 kg patient as it falls within the recommended range of 4-6 mL/kg for ARDS patients to prevent ventilator-induced lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase respiratory rate</strong>: Increasing the respiratory rate is not necessary in this situation as the paCO2 (38 mmHg) and pH (7.38) indicate normal ventilation and no significant respiratory acidosis (paCO2 is normal).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In ARDS management, if the patient remains hypoxemic despite a high FiO2, the next step is to increase the PEEP to improve oxygenation while maintaining lung-protective ventilation strategies.</span></span></span></p>",
    "correct_choice_id": 46433,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9369,
    "choices": [
      {
        "id": 37443,
        "text": "<p><span style=\"font-size:12.0pt;\">A for airway</span></p>"
      },
      {
        "id": 37444,
        "text": "<p><span style=\"font-size:12.0pt;\">B for breathing</span></p>"
      },
      {
        "id": 37445,
        "text": "<p><span style=\"font-size:12.0pt;\">C for circulation</span></p>"
      },
      {
        "id": 37446,
        "text": "<p><span style=\"font-size:12.0pt;\">D for dehydration</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In PALS ABCDE all pairs are matched correctly except? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q6280079",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507170,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) D for dehydration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All pairs are correctly matched except D for dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here it Should be D for disability</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Pediatric Basic and Advanced Life Support (PALS) mnemonic \u201cABCDE\u201d stands for as follow -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A - Airway</span></p><p><span style=\"font-size:12.0pt;\">B - Breathing</span></p><p><span style=\"font-size:12.0pt;\">C - Circulation</span></p><p><span style=\"font-size:12.0pt;\">D - Disability</span></p><p><span style=\"font-size:12.0pt;\">E - Exposure</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">First, life-threatening airway problems are assessed and treated; second, life-threatening breathing problems are assessed and treated; and so on.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In PALS, the \"D\" in the ABCDE mnemonic stands for Disability, which involves assessing the child\u2019s neurological status.</span></p>",
    "correct_choice_id": 37446,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57639,
    "choices": [
      {
        "id": 229925,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 day</span></span></p>"
      },
      {
        "id": 229926,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3-4 days</span></span></p>"
      },
      {
        "id": 229927,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7-10 days</span></span></p>"
      },
      {
        "id": 229928,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-3 weeks</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient suffered from severe chest pain and expired. Which of the following is the likely age of infarct from the image of the cardiac biopsy shown here? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf15.jpg\" style=\"height:305px; width:400px\" /></span></span></span></p>",
    "unique_key": "Q7619974",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507149,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 1 day</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The cardiac biopsy image shows significant neutrophilic infiltration, which is a hallmark of early myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Neutrophilic infiltration in myocardial tissue occurs in two phases: early (within 24 hours) and late (after 24 hours). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the early phase, neutrophils begin to infiltrate the infarcted tissue within the first 24 hours, but their numbers are relatively low. By the second and third days, neutrophil infiltration becomes more pronounced as the body attempts to clear the dead tissue. However, after 72 hours, neutrophils start to be replaced by macrophages. In this question, the presence of numerous neutrophils indicates that the infarct age is close to 1 day, as significant neutrophil accumulation typically peaks around 24 to 48 hours.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 3-4 days</span></strong><span style=\"font-size:12.0pt\">: By this time, neutrophils are starting to be replaced by <strong>macrophages</strong>, which are responsible for further cleanup and early stages of healing. Therefore, extensive neutrophilic infiltration would not be seen at this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 7-10 days</span></strong><span style=\"font-size:12.0pt\">: At this point<strong>, granulation tissue</strong> is starting to form, and macrophages predominate the area. Neutrophils would not be the primary cells observed, making this answer incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 2-3 weeks</span></strong><span style=\"font-size:12.0pt\">: By 2-3 weeks, granulation tissue is well established, and the repair process is progressing toward fibrosis. Neutrophils would not be present in large numbers at this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brisk neutrophilic infiltration is a characteristic finding in myocardial tissue within the first 24 hours of infarction. <strong>The peak of neutrophil presence occurs</strong> <strong>around the second and third days</strong>, followed by the transition to macrophages.</span></span></span></p>",
    "correct_choice_id": 229925,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 31799,
    "choices": [
      {
        "id": 127066,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Initiate an insulin intravenous infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127067,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Give an insulin stat dose of 0.1 units/kg intravenously, followed by an infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127068,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Administer normal saline for the first hour followed by insulin infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127069,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Continue with intravenous fluids without insulin administration</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#343541\">A 10-year-old child with a known history of Type 1 Diabetes Mellitus presents to the emergency department with symptoms of increased thirst, frequent urination, abdominal pain, and confusion. On examination, the child appears dehydrated and is breathing rapidly. Laboratory tests reveal a blood glucose level of 400 mg/dl and blood gas analysis is indicative of acidosis. Initial treatment with intravenous fluids has been started. What is the most appropriate next step in the management of this patient? </span></span></span></p>",
    "unique_key": "Q7902893",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507150,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ans. C) <span style=\"color:#343541\">Administer normal saline for the first hour followed by insulin infusion at 0.1 units/kg/hour</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation is suggestive of diabetic ketoacidosis (DKA), which is an acute, life-threatening complication of diabetes mellitus that typically requires IV fluids and insulin administration to correct hyperglycemia and halt ketogenesis. According to latest guidelines for management of DKA in children first IV fulids are administered for one hour, then insulin is adminsitered by IV infusion at a rate of 0.1 U/kg/hour.&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other options:</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Give an insulin stat dose of 0.1 units/kg intravenously, followed by an infusion at 0.1 units/kg/hour:</strong> According to new guidelines, bolus dose of insulin is not used for treatment of DKA particularly in children as it increases the risk of cerebral edema in many children.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Initiate an insulin intravenous infusion at 0.1 units/kg/hour:</strong> While insulin infusion is an essential part of DKA management, according to new guidelines, it&#39;s typically given one hour after the adminsitration of IV fluids.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Continue with intravenous fluids without insulin administration:</strong> This would not address the hyperglycemia and ketosis and is therefore inadequate for the treatment of DKA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">According to latest guidelines for management of DKA in children first IV fulids are administered for one hour, then insulin is adminsitered by IV infusion at a rate of 0.1 U/kg/hour.&nbsp;</span></span></p>",
    "correct_choice_id": 127068,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4558,
    "choices": [
      {
        "id": 18208,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">X ray</span></p>"
      },
      {
        "id": 18209,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Proton</span></p>"
      },
      {
        "id": 18210,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Neutron</span></p>"
      },
      {
        "id": 18211,
        "text": "<p><span style=\"font-size:12.0pt;\">Electron</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The Bragg peak effect is pronounced in:&nbsp;</span>(NEET PG 2018)</p>",
    "unique_key": "Q1795538",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507139,
    "difficulty_level": "beginner",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Proton</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bragg peak effect is a phenomenon seen with proton therapy, where there is a sharp increase in radiation dose deposition at a specific depth, followed by a rapid decrease. This makes proton therapy particularly effective for targeting tumors with minimal damage to surrounding tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. X-ray:&nbsp;</strong>X-rays do not exhibit the Bragg peak; they deposit radiation relatively uniformly along their path, leading to more widespread tissue damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Neutron:&nbsp;</strong>Neutrons, while used in certain types of radiation therapy, do not exhibit a Bragg peak. Their interactions are different, primarily involving nuclear reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Electron:&nbsp;</strong>Electrons do have a distinct depth-dose distribution, which includes a peak dose at a certain depth, but it is not as sharp or pronounced as the Bragg peak seen with protons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Proton beam therapy characteristics:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It has marked effect with increased depth in the soft tissues.</span></li><li><span style=\"font-size:12.0pt;\">Bragg's peak is their peculiar feature.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ideal agents for treating deep seated tumors.</strong></span></li><li><span style=\"font-size:12.0pt;\">Agent of choice for treatment of clival chordomas.</span></li></ul>",
    "correct_choice_id": 18209,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54937,
    "choices": [
      {
        "id": 219209,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CK-MB</span></span></span></p>"
      },
      {
        "id": 219210,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lactate dehydrogenase 1 (LDH 1)</span></span></span></p>"
      },
      {
        "id": 219211,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac Troponin I</span></span></span></p>"
      },
      {
        "id": 219212,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia modified albumin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the earliest marker for myocardial infarction? (FMGE JULY 2024)</span></span></span></p>",
    "unique_key": "Q5286238",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507154,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Ischemia modified albumin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia-modified albumin (IMA) is considered one of the <strong>earliest markers</strong> for myocardial infarction (MI). It can be detected in the blood within minutes of ischemia and before any significant myocardial necrosis occurs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The novelty of IMA lies in its ability to indicate ischemia even before traditional markers like CK-MB or Troponin I rise, making it particularly useful in the early diagnosis of MI. Its primary utility, however, is in its negative predictive value&mdash;if IMA levels are normal, it&#39;s more likely that the patient is not experiencing an MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart Fatty Acid Binding Protein (H-FABP), one more novel early</span></span></strong><span style=\"font-size:12.0pt\"> marker is noted for its rapid response following myocardial injury. It can be detected early in the blood after the onset of a heart attack, making it a valuable tool for early diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CK-MB:&nbsp;</span></strong><span style=\"font-size:12.0pt\">CK-MB is a marker of myocardial injury that typically rises within <strong>3-4 hours after</strong> the onset of infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lactate dehydrogenase 1 (LDH 1):&nbsp;</span></strong><span style=\"font-size:12.0pt\">LDH 1 is a <strong>late marker</strong> of myocardial infarction, typically rising <strong>24-48 hours after the onset</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note -</span></strong> <span style=\"font-size:12.0pt\">LDH reacts with<strong> Triphenyl Tetrazole Chloride</strong> <strong>dye</strong>, which is used to visually differentiate between normal and infarcted cardiac tissue during diagnostic procedures. In the presence of this dye, <strong>normal cardiac tissue produces a big red color, while infarcted areas show a yellowish appearance.</strong> This color differentiation helps in identifying and assessing the extent of myocardial damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cardiac Troponin I:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Cardiac Troponins, especially Troponin I, are highly specific for myocardial injury and are the gold standard for diagnosing MI. However, they typically rise <strong>within 4-6 hours after the onset</strong>, making them less useful as the earliest marker compared to IMA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia modified albumin (IMA) is an early biomarker for myocardial infarction, detectable shortly after ischemia begins, and is particularly valuable for its ability to rule out MI when levels are normal.</span></span></span></p>",
    "correct_choice_id": 219212,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54974,
    "choices": [
      {
        "id": 219357,
        "text": "<p><span style=\"font-size:12.0pt;\">Louse</span></p>"
      },
      {
        "id": 219358,
        "text": "<p><span style=\"font-size:12.0pt;\">Tick</span></p>"
      },
      {
        "id": 219359,
        "text": "<p><span style=\"font-size:12.0pt;\">Mite</span></p>"
      },
      {
        "id": 219360,
        "text": "<p><span style=\"font-size:12.0pt;\">Flea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young boy came to Derma OPD with complaints of severe itching at night. On examination, burrows are seen over intertriginous areas, axillae, umbilicus, and between digits. The disease is transmitted by? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q2122251",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507138,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Mite</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The boy's symptoms, including severe nocturnal itching and the presence of burrows in specific body areas (intertriginous regions, axillae, umbilicus, and between digits), are classic signs of <strong>scabies</strong>. Scabies is a skin condition caused by infestation with the itch mite <strong>Sarcoptes scabiei var. hominis</strong>. The mite burrows into the skin, causing intense itching, especially at night. The areas affected (often referred to as the <strong>circle of Hebra</strong>) are characteristic for scabies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/28/screenshot-2024-08-28-094514.jpg\" alt=\"\" width=\"150\" height=\"267\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Circle of Hebra</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/28/screenshot-2024-08-28-094542.jpg\" alt=\"\" width=\"300\" height=\"130\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mites</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Louse</strong>: Lice infestation, known as pediculosis, typically causes itching but does not present with burrows in the skin or nocturnal itching. Lice infest hair and clothing rather than burrowing into the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tick</strong>: Ticks are ectoparasites that attach to the skin and can transmit various diseases, such as Lyme disease. However, they do not cause the characteristic burrows or intense nocturnal itching seen in scabies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Flea</strong>: Flea bites cause itchy red spots, primarily on the lower legs, but fleas do not burrow into the skin or cause the described distribution of burrows.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scabies is caused by the mite <strong>Sarcoptes scabiei var. hominis</strong>, which burrows into the skin, causing intense itching, particularly at night, and burrows in characteristic areas such as the axillae, umbilicus, and between the digits.</span></p>",
    "correct_choice_id": 219359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10186,
    "choices": [
      {
        "id": 40710,
        "text": "<p><span style=\"font-size:18px;\">First come first treated basis</span></p>"
      },
      {
        "id": 40711,
        "text": "<p><span style=\"font-size:18px;\">Green labels are for those who need to be transported on priority</span></p>"
      },
      {
        "id": 40712,
        "text": "<p><span style=\"font-size:18px;\">Moribund patients receive the lowest priority</span></p>"
      },
      {
        "id": 40713,
        "text": "<p><span style=\"font-size:18px;\">Most commonly used system is three color code system</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>During disaster management, triage is conducted to ensure proper treatment of casualties. What are the accurate aspects of the triage process carried out at the site of the disaster? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q9418663",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507165,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Moribund patients receive the lowest priority</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In Triage, these patients are given different color coding as mentioned below \u2013</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125428.jpg\" alt=\"\" width=\"700\" height=\"286\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In disaster triage, moribund patients receive the lowest priority, allowing medical resources to be focused on patients with a higher chance of survival.</span></p>",
    "correct_choice_id": 40712,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10172,
    "choices": [
      {
        "id": 40654,
        "text": "<p><span style=\"font-size:18px;\">Village</span></p>"
      },
      {
        "id": 40655,
        "text": "<p><span style=\"font-size:18px;\">Centre</span></p>"
      },
      {
        "id": 40656,
        "text": "<p><span style=\"font-size:18px;\">District</span></p>"
      },
      {
        "id": 40657,
        "text": "<p><span style=\"font-size:18px;\">State</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>What constitutes the primary administrative unit in India? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q7467276",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507156,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) District</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The principal unit of administration in India is the district, which is administered by a Collector.</span></li><li><span style=\"font-size:18px;\">The district is the basic unit of administration in India and is responsible for implementing various government schemes and programs at the grassroots level. It is headed by a District Collector or Deputy Commissioner, who is responsible for maintaining law and order, revenue administration, and developmental activities in the district.</span></li><li><span style=\"font-size:18px;\">Under districts are the sub-divisions, tehsils or talukas, municipalities or corporations, villages, panchayats, etc.</span></li><li><span style=\"font-size:18px;\">According to 2023 data, there are 766 districts in India</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The district serves as the principal administrative unit in India, playing a vital role in governance and implementation of government policies at the grassroots level.</span></p>",
    "correct_choice_id": 40656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2833,
    "choices": [
      {
        "id": 11317,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxaloacetate</span></p>"
      },
      {
        "id": 11318,
        "text": "<p><span style=\"font-size:12.0pt;\">Acetyl CoA</span></p>"
      },
      {
        "id": 11319,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactate</span></p>"
      },
      {
        "id": 11320,
        "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not glucogenic?(INICET NOV 2021)</span></p>",
    "unique_key": "Q1191085",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507136,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Acetyl coenzyme A</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Acetyl CoA is not glucogenic. It enters the citric acid cycle (Kreb's cycle) for energy production and cannot be directly converted into glucose. It is primarily used for energy generation in the form of ATP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oxaloacetate: </strong>Oxaloacetate is a glucogenic compound. It can be converted into glucose through a series of enzymatic reactions in the gluconeogenesis pathway. This makes it a precursor for glucose synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lactate: </strong>Lactate is a glucogenic compound. It can be converted into pyruvate in the Cori cycle, and pyruvate can then be used in gluconeogenesis to produce glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pyruvate: </strong>Pyruvate is a glucogenic compound. It serves as a central molecule in both glycolysis and gluconeogenesis, making it a key intermediate in the conversion of various substrates into glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetyl CoA is not a glucogenic compound as it cannot be directly converted into glucose, unlike oxaloacetate, lactate, and pyruvate, which are glucogenic and contribute to glucose synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Substrates of gluconeogenesis (mostly 3C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Pyruvate (3C)</span></li><li><span style=\"font-size:12.0pt;\">Lactate (3C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Propionic acid (3C)</span></li><li><span style=\"font-size:12.0pt;\">Glycerol (3C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Glucogenic amino acids (18 amino acids)</span></li><li><span style=\"font-size:12.0pt;\">Both Ketogenic &amp; Glucogenic amino acids</span></li><li><span style=\"font-size:12.0pt;\">Any TCA Intermediate (forms oxaloacetate which can enter gluconeogenesis)</span></li></ol>",
    "correct_choice_id": 11318,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10327,
    "choices": [
      {
        "id": 41274,
        "text": "<p><span style=\"font-size:12.0pt;\">P-53</span></p>"
      },
      {
        "id": 41275,
        "text": "<p><span style=\"font-size:12.0pt;\">K-ras</span></p>"
      },
      {
        "id": 41276,
        "text": "<p><span style=\"font-size:12.0pt;\">BcI-2</span></p>"
      },
      {
        "id": 41277,
        "text": "<p><span style=\"font-size:12.0pt;\">BAK</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the anti-apoptotic factor among the following: (NEET PG 2019)</span></p>",
    "unique_key": "Q3168712",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507148,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bcl-2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anti-apoptotic factor among the following is BcI-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apoptosis is a process of programmed cell death that occurs in multicellular organisms. It is a highly regulated process that involves a complex network of proteins and signaling pathways. Among the proteins involved in apoptosis are two families of proteins known as the Bcl-2 family and the caspase family.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bcl-2 family of proteins includes both pro-apoptotic and anti-apoptotic members. The pro-apoptotic members include Bax, Bak, and others, while the anti-apoptotic members include Bcl-2, Bcl-XL, and others. The balance between pro-apoptotic and anti-apoptotic members of the Bcl-2 family is important in determining whether a cell will undergo apoptosis or not.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. P-53:</strong> P-53 is a tumor suppressor protein known for its role in preventing cancer. It can induce apoptosis but is generally considered a promoter of cell cycle arrest and DNA repair in response to DNA damage, rather than being anti-apoptotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. K-ras:</strong> K-ras is an oncogene that, when mutated, contributes to cancer progression by promoting cellular proliferation and survival, not directly inhibiting apoptosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BAK:</strong> BAK, like Bax, is a pro-apoptotic member of the Bcl-2 family. It promotes apoptosis by facilitating mitochondrial outer membrane permeabilization, which is a critical step in the activation of the apoptotic pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bcl-2's anti-apoptotic properties make it a key player in cellular survival and stress response. Its ability to inhibit key steps in the apoptotic process distinguishes it from other proteins like P-53, K-ras, and BAK, which have different roles in the regulation of cell death and proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-395.jpg\" alt=\"\" width=\"1000\" height=\"536\"></span></p>",
    "correct_choice_id": 41276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4513,
    "choices": [
      {
        "id": 18028,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of vitamin K leads to hypercoagulability.</span></span></span></p>"
      },
      {
        "id": 18029,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a water-soluble vitamin.</span></span></span></p>"
      },
      {
        "id": 18030,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged use of antibiotics leads to vitamin K deficiency.</span></span></span></p>"
      },
      {
        "id": 18031,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menaquinone is the dietary source of vitamin K found in green vegetables.</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true about vitamin K? (</span></span>NEET PG 2018)</p>",
    "unique_key": "Q1300906",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507157,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Prolonged use of antibiotics leads to Vitamin K deficiency </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C:</strong> Prolonged use of antibiotics leads to vitamin K deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True. Prolonged use of certain antibiotics can disrupt the normal gut flora responsible for synthesizing vitamin K. This disruption can lead to a deficiency in vitamin K, which is essential for blood clotting.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Deficiency of vitamin K leads to hypercoagulability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False. Vitamin K deficiency does not lead to hypercoagulability. Instead, it leads to hypocoagulability, which means impaired blood clotting. Vitamin K is essential for the activation of clotting factors in the blood, and its deficiency can result in bleeding disorders, not excessive blood clotting.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B.</strong> It is a water-soluble vitamin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False. Vitamin K is not a water-soluble vitamin; it is a fat-soluble vitamin. Fat-soluble vitamins, including vitamins A, D, E, and K, are absorbed with dietary fats and are stored in the body&#39;s fatty tissues.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D.</strong> Menaquinone is the dietary source of vitamin K found in green vegetables.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partially true. While menaquinone (vitamin K2) is a form of vitamin K, the primary dietary source of vitamin K found in green vegetables is phylloquinone (vitamin K1). Both forms of vitamin K are essential for various biological functions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin K is a <strong>fat-soluble</strong> vitamin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sources of vitamin K:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Green leafy vegetables (<strong>Phylloquinone/</strong> Vitamin K1)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synthesis by intestinal bacteria (<strong>Menaquinones</strong>/Vitamin K2)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menadione&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is synthetic compound metabolized to phylloquinone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In normal adult dietary deficiency seldom occurs since the intestinal bacterial synthesis is sufficient to meet the needs of the body. However, deficiency can occur in conditions of malabsorption of lipids due to obstructive jaundice, chronic pancreatitis, sprue, etc. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged antibiotic therapy and gastrointestinal infections with diarrhea will destroy the bacterial flora and can also lead to vitamin K deficiency</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin K is necessary for coagulation. Factors dependent on vitamin K are <strong>Factor II (prothrombin); Factor VII (SPCA); Factor IX (Christmas factor); Factor X (Stuart Power factor)</strong> therefore deficiency will to lead to bleeding disorders.</span></span></span></p>",
    "correct_choice_id": 18030,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4852,
    "choices": [
      {
        "id": 19383,
        "text": "<p><span style=\"font-size:12.0pt;\">Spermatogonia</span></p>"
      },
      {
        "id": 19384,
        "text": "<p><span style=\"font-size:12.0pt;\">Intestinal epithelial cells</span></p>"
      },
      {
        "id": 19385,
        "text": "<p><span style=\"font-size:12.0pt;\">Neurons</span></p>"
      },
      {
        "id": 19386,
        "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow/ erythroid precursor cells</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A child with acute lymphoblastic leukemia undergoes prophylactic irradiation prior to autologous hematopoietic stem cell transplantation. Which of the following will be the least affected?&nbsp;(NEET PG 2021)</span></p>",
    "unique_key": "Q9704876",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507158,
    "difficulty_level": "beginner",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Neurons</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neurons (Central nervous system) are the least affected by irradiation among the options given, due to their highly differentiated and non-dividing nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option.&nbsp;A. Spermatogonia</strong>: These are germ cells that continually divide and are highly sensitive to radiation, which can lead to infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option.&nbsp;B. Intestinal epithelial cells</strong>: These cells have a high turnover rate, making them very sensitive to radiation, which can result in gastrointestinal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option.&nbsp;D. Bone marrow/erythroid precursor cells</strong>: These cells are among the most sensitive to radiation due to their role in rapidly producing new blood cells, leading to potential marrow suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/17/screenshot-2024-05-17-171435.JPG\" alt=\"\" width=\"1000\" height=\"557\"></strong></span></p>",
    "correct_choice_id": 19385,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24750,
    "choices": [
      {
        "id": 98961,
        "text": "<p><span style=\"font-size:18px;\">Mode is affected by extreme values</span></p>"
      },
      {
        "id": 98962,
        "text": "<p><span style=\"font-size:18px;\">Mean is affected by extreme values</span></p>"
      },
      {
        "id": 98963,
        "text": "<p><span style=\"font-size:18px;\">Median is calculated by overall observations</span></p>"
      },
      {
        "id": 98964,
        "text": "<p><span style=\"font-size:18px;\">Mode can be used as a qualitative data descriptor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following statements is false for descriptors of central tendency?</strong><i><strong> [INICET MAY 2023]</strong></i></span></p>",
    "unique_key": "Q8687178",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507167,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Mode is affected by extreme values</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Extreme values in a given dataset do not influence the mode.</span></li><li><span style=\"font-size:18px;\">Mode is the most frequent or most commonly occurring value in a distribution.</span></li><li><span style=\"font-size:18px;\">It is uninfluenced by extreme values and can be used to describe qualitative data</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Mean is affected by extreme values:</strong> This is true. Extreme values (outliers) can significantly affect the mean, making it an unreliable measure of central tendency in skewed distributions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Median is calculated by overall observations:</strong> This is true. The median is determined by arranging all observations in order and finding the middle value, or the average of the two middle values if the number of observations is even.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Mode can be used as a qualitative data descriptor:</strong> This is true. The mode is applicable to qualitative data as it represents the most frequently occurring category or value.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The mode is not affected by extreme values and can be used to describe qualitative data.</span></li><li><span style=\"font-size:18px;\">In contrast, the mean is affected by extreme values, and the median is a robust measure of central tendency that is calculated using overall observations.</span></li></ul>",
    "correct_choice_id": 98961,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55760,
    "choices": [
      {
        "id": 222473,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardioversion</span></p>"
      },
      {
        "id": 222474,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.3 mg per kg</span></p>"
      },
      {
        "id": 222475,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.2 mg/kg</span></p>"
      },
      {
        "id": 222476,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.1 mg/kg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child with stable vitals and ECG showing PSVT. What is the appropriate management? (NEET PG 2024)</span></p>",
    "unique_key": "Q1166959",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507143,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Adenosine 0.1 mg/kg</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The management of paroxysmal supraventricular tachycardia (PSVT) in a stable child begins with pharmacological intervention rather than immediate cardioversion. Adenosine is the drug of choice for PSVT due to its ability to temporarily block the atrioventricular node, effectively terminating the arrhythmia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial dose of adenosine recommended is 0.1 mg/kg given as a rapid IV bolus over 1-3 seconds. If there is no response, subsequent doses can be increased to 0.2 mg/kg, and if necessary, 0.3 mg/kg can be administered under monitored conditions. Rapid bolus administration is essential, followed by a 5-10 ml of saline flush to ensure the drug reaches systemic circulation quickly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cardioversion:</strong> Cardioversion is typically reserved for cases where the patient is unstable or when pharmacological management fails. In a stable patient, the initial approach is to use adenosine to terminate the PSVT without the need for electrical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenosine 0.3 mg per kg:</strong> While this dosage of adenosine can be used if initial doses do not work, it is not the starting dose. The initial dose should be lower, at 0.1 mg/kg, to minimize potential adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenosine 0.2 mg/kg:</strong> This dose of adenosine is appropriate for a second attempt if the initial dose (0.1 mg/kg) does not resolve the PSVT. It is not the first-line dose but can be escalated to after the initial dose fails.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For stable PSVT in children, adenosine is the first-line treatment, starting at a dose of 0.1 mg/kg. If this dose is ineffective, the dose may be escalated in subsequent attempts.</span></p>",
    "correct_choice_id": 222476,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9875,
    "choices": [
      {
        "id": 39466,
        "text": "<p><span style=\"font-size:12.0pt;\">Arnold-Chiari malformation</span></p>"
      },
      {
        "id": 39467,
        "text": "<p><span style=\"font-size:12.0pt;\">Dandy-Walker syndrome</span></p>"
      },
      {
        "id": 39468,
        "text": "<p><span style=\"font-size:12.0pt;\">Arachnoid villi malformation</span></p>"
      },
      {
        "id": 39469,
        "text": "<p><span style=\"font-size:12.0pt;\">Aqueductal stenosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of ventriculomegaly in newborns? (NEET PG 2018)</span></p>",
    "unique_key": "Q4071168",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507151,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Aqueductal stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aqueductal stenosis is the most common cause of ventriculomegaly (enlargement of ventricles of the brain) in newborns. It is a congenital condition where there is narrowing or obstruction of the cerebral aqueduct, a small channel that connects the third and fourth ventricles in the brain. This obstruction can result in an enlargement of the ventricles, which can lead to hydrocephalus (accumulation of cerebrospinal fluid in the brain). Arnold-Chiari malformation, Dandy-Walker syndrome, and arachnoid villi malformation are other conditions that can cause ventriculomegaly, but they are less common causes than aqueductal stenosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/23/screenshot-2024-02-23-124444.jpg\" alt=\"\" width=\"300\" height=\"190\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Arnold chiari malformation:&nbsp;</strong>Arnold chiari malformation will have downward displacement of cerebellum and brainstem. This is not the most commonest cause of ventriculomegaly</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dandy walker malformation:&nbsp;</strong>Dandy walker malformation will have cerebellar hypoplasia with hydrocephalus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Arachnoid villi malformation:&nbsp;</strong>Arachnoid villi malformation is not the most commonest cause</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aqueductal stenosis is the leading cause of ventriculomegaly in newborns due to the narrowing or obstruction of the cerebral aqueduct, leading to hydrocephalus.</span></p>",
    "correct_choice_id": 39469,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7434,
    "choices": [
      {
        "id": 29704,
        "text": "<p><span style=\"font-size:12pt;\">Seborrheic dermatitis</span></p>"
      },
      {
        "id": 29705,
        "text": "<p><span style=\"font-size:12pt;\">Atopic dermatitis</span></p>"
      },
      {
        "id": 29706,
        "text": "<p><span style=\"font-size:12pt;\">Allergic contact dermatitis</span></p>"
      },
      {
        "id": 29707,
        "text": "<p><span style=\"font-size:12pt;\">Erysipelas</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">What is the most likely diagnosis for a 13-year-old boy with a history of chronic and recurrent itchy flexural lesions, considering his family history of asthma?</span>(NEET PG 2018)</p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1294.jpg\" alt=\"\" width=\"300\" height=\"240\"></span></p>",
    "unique_key": "Q6500664",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507171,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B. Atopic dermatitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image displays <strong>scratch marks and excoriations </strong>caused by <strong>pruritic lesions </strong>at a <strong>flexural site. </strong>The patient has a personal <strong>history</strong> of <strong>chronic and recurrent course</strong>, and there is also a <strong>family history of atopy</strong>, specifically <strong>asthma</strong>. <strong>These findings suggest a diagnosis of atopic dermatitis (AD) or atopic eczema (AE).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Atopic dermatitis (AD):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a <strong>chronic inflammatory condition </strong>that tends to <strong>persist</strong> or exhibit <strong>chronic relapses.</strong></span></li><li><span style=\"font-size:12.0pt;\">In infants, the <strong>first site </strong>of involvement is often the <strong>face.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Flexural</strong> distribution is observed in both the <strong>childhood and adult</strong> phases of the condition, while in the <strong>infantile phase</strong>,<strong> extensor</strong> distribution is more typical.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Atopic eczema can be divided into <strong>3 phases:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Infantile</span></li><li><span style=\"font-size:12pt;\">Childhood</span></li><li><span style=\"font-size:12pt;\">Adult</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1295.jpg\" alt=\"\" width=\"1000\" height=\"314\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atopic eczema infantile variant with face affected:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1296.jpg\" alt=\"\" width=\"300\" height=\"272\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Atopic dermatitis typically presents with <strong>erythematous papules or papulovesicular</strong> lesions, often appearing in early childhood.</span></li><li><span style=\"font-size:12.0pt;\">As the condition progresses, the lesions may evolve into <strong>excoriated and lichenified</strong> areas. Atopic dermatitis is commonly associated with <strong>secondary infections</strong> and skin dryness.</span></li><li><span style=\"font-size:12.0pt;\">In the diagnosis of atopic dermatitis, the <strong>UK refinement</strong> of the <strong>Hanifin &amp; Rajka criteria</strong> is employed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>UK refinement of Hanifin &amp; Rajka\u2019s diagnostic criteria of atopic dermatitis (Eczema).</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">An <strong>itchy</strong> skin condition (or parental <strong>report of scratching or rubbing</strong> in a child)</span></li><li><span style=\"font-size:12pt;\">Plus<strong>, three</strong> or more of the following</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Onset <strong>below age 2 years</strong> (not used if child is under 4 years)</span></li><li><span style=\"font-size:12.0pt;\">History of <strong>skin crease</strong> involvement (including <strong>cheeks</strong> in children under 10 years)</span></li><li><span style=\"font-size:12.0pt;\">History of a generally <strong>dry skin</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Personal history</strong> of other atopic disease (or history of any <strong>atopic disease</strong> in a first degree <strong>relative</strong> in children under 4 years)</span></li><li><span style=\"font-size:12.0pt;\">Visible <strong>flexural dermatitis</strong> (or dermatitis of <strong>cheeks/ forehead</strong> and <strong>outer limbs</strong> in children under 4 years)</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical features of AD include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Dennie-morgan fold under lower eyelid</span></li><li><span style=\"font-size:12pt;\"><strong>Allergic shiners \u2013</strong> periorbital pigmentation</span></li><li><span style=\"font-size:12pt;\"><strong>Allergic salute</strong> \u2013 horizontal groove on dorsum of nasal bridge</span></li></ul><p style=\"text-align:center;\">&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1297.jpg\" alt=\"\" width=\"300\" height=\"275\"></span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><strong>Fig: Dennie-morgan fold</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Complications of AD:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Staphylococcus aureus</strong> is the most common organism to cause <strong>secondary infections</strong> in the lesions of atopic dermatitis.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option A. Seborrheic dermatitis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:black;font-size:12pt;\">This is a chronic condition that primarily affects <strong>sebum-rich areas</strong> of the body such as the <strong>scalp, face, and central chest.</strong></span></li><li><span style=\"background-color:white;color:black;font-size:12pt;\">It's characterized by <strong>yellowish, greasy scales</strong> and underlying <strong>erythema as shown in the image below.</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/1_ef9oUNS.jpg\" alt=\"\" width=\"300\" height=\"225\"></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">While it can be itchy, its distribution and features are different from the description given.</span></li><li><span style=\"color:black;font-size:12pt;\">There is <strong>no direct association</strong> between <strong>seborrheic dermatitis</strong> and a <strong>family history of asthma.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option C.&nbsp;Allergic contact dermatitis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">This results from direct skin contact with <strong>allergens</strong>. It's an <strong>immunological response</strong> to a substance the individual has become sensitized to.</span></li><li><span style=\"color:black;font-size:12pt;\">The lesions would be more correlated with contact to specific allergens, and it's <strong>not typically chronic or recurrent</strong> unless there is repeated exposure to the same allergen.</span></li><li><span style=\"color:black;font-size:12pt;\">The distribution would be more in line with <strong>areas that contacted the allergen</strong>, rather than the typical flexural pattern described.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option D. Erysipelas:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Erysipelas is an <strong>acute bacterial</strong> skin infection, typically caused by <strong>Group A Streptococcus.</strong></span></li><li><span style=\"color:black;font-size:12pt;\">It presents as a <strong>well-demarcated, raised, erythematous, and tender skin lesion</strong>, often accompanied by <strong>systemic symptoms like fever</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\">This condition is <strong>acute</strong>, <strong>not chronic or recurrent</strong> as described in the scenario.</span></li><li><span style=\"color:black;font-size:12pt;\">There's <strong>no association</strong> with a <strong>family history</strong> of asthma.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">Identify <strong>atopic dermatitis</strong> as a <strong>chronic, pruritic inflammatory</strong> skin disease commonly associated with <strong>flexural distribution</strong> of eczematous lesions and a <strong>family history</strong> of atopic conditions, such as asthma.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Reference:</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rooks textbook of dermatology- 9<sup>th</sup> Edition volume 2 Chapter 41 page no 41.1, 41.2, 41.13-19</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rooks\u2019 textbook of dermatology- 9<sup>th</sup> Edition volume 3 Chapter 149 page no 149.21</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online resources:</strong></span></p><p><a href=\"https://www.jaad.org/article/S0190-9622(13)01095-5/fulltext\"><span style=\"font-size:12.0pt;\"><strong><u>https://www.jaad.org/article/S0190-9622(13)01095-5/fulltext</u></strong></span></a></p>",
    "correct_choice_id": 29705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54298,
    "choices": [
      {
        "id": 216661,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM1</span></span></span></p>"
      },
      {
        "id": 216662,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM2</span></span></span></p>"
      },
      {
        "id": 216663,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM3</span></span></span></p>"
      },
      {
        "id": 216664,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">REM</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Identify the stage of sleep based on the EEG shown below:</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-131403.jpg\" style=\"height:246px; width:500px\" /></span></span></span></p>",
    "unique_key": "Q7209268",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507172,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D) REM</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The EEG provided shows a pattern that mimics an awake state, which is indicative of REM (Rapid Eye Movement) sleep. REM sleep is characterized by specific EEG, EOG (electro-oculogram), and EMG (electromyogram) patterns:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EEG (Electroencephalogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> During REM sleep, the EEG shows low amplitude, mixed frequency activity that resembles the awake state. This is in contrast to the high amplitude, low-frequency waves seen in NREM (Non-Rapid Eye Movement) sleep stages.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EOG (Electro-oculogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The EOG shows rapid eye movements, which are characteristic of REM sleep. These movements are visible as sharp spikes or fluctuations in the EOG tracing.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EMG (Electromyogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The EMG shows muscle atonia or paralysis, which is another hallmark of REM sleep. This paralysis prevents the sleeper from acting out their dreams. Only the diaphragm and extraocular muscles remain active during REM sleep.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. NREM1:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the lightest stage of sleep, characterized by a transition from wakefulness to sleep. The EEG shows a mix of alpha and theta waves, with some slow eye movements, but it does not resemble the awake state as closely as REM sleep does.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. NREM2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This stage is marked by sleep spindles and K-complexes on the EEG. It is a deeper stage of sleep than NREM1 but does not show the rapid eye movements or muscle atonia seen in REM sleep.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. NREM3:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Also known as slow-wave sleep (SWS), this stage is characterized by high amplitude, low-frequency delta waves on the EEG. It is the deepest stage of NREM sleep and does not resemble the awake state.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">REM sleep is characterized by EEG patterns similar to wakefulness, rapid eye movements on EOG, and muscle atonia on EMG.</span></span></span></p>",
    "correct_choice_id": 216664,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2890,
    "choices": [
      {
        "id": 11545,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proteins</span></span></span></p>"
      },
      {
        "id": 11546,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbohydrates</span></span></span></p>"
      },
      {
        "id": 11547,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mono-unsaturated fatty acids</span></span></span></p>"
      },
      {
        "id": 11548,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Poly-unsaturated fatty acids</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which require maximum energy for assimilation? (</span></span>INICET Nov 2021)</p>",
    "unique_key": "Q5352357",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507174,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Proteins </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A. Proteins:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proteins are complex macromolecules consisting of amino acids.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They require a significant amount of energy for assimilation because the body needs to break them down into individual amino acids, which are then used for various metabolic processes, including energy production.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B. Carbohydrates:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbohydrates are a primary source of energy for the body.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are relatively easy to assimilate as they are broken down into glucose, which can be readily used for energy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C. Mono-unsaturated fatty acids:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mono-unsaturated fatty acids are a type of dietary fat found in foods like olive oil and avocados.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They require less energy for assimilation compared to proteins because they can be broken down relatively easily and used for energy or stored as fat.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D. Poly-unsaturated fatty acids:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poly-unsaturated fatty acids, such as omega-3 and omega-6 fatty acids, are essential fats found in certain foods.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Similar to mono-unsaturated fatty acids, they require less energy for assimilation compared to proteins.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteins require the maximum energy for assimilation among the options listed, as they need to be broken down into individual amino acids for various metabolic processes, including energy production.</span></span></p>",
    "correct_choice_id": 11545,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55413,
    "choices": [
      {
        "id": 221113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anemia</span></span></p>"
      },
      {
        "id": 221114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Preeclampsia</span></span></p>"
      },
      {
        "id": 221115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Neural tube defects</span></span></p>"
      },
      {
        "id": 221116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gestational diabetes</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following can be prevented by folic acid supplementation in pregnancy? (FMGE JULY 2024)</span></span></p>",
    "unique_key": "Q5083754",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507175,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Neural tube defects</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folic acid supplementation before conception and during early pregnancy significantly reduces the risk of neural tube defects (NTDs) in the developing fetus. Neural tube defects are serious birth defects of the brain and spine, such as spina bifida and anencephaly. Adequate folic acid intake is crucial during the early stages of pregnancy, often before a woman even knows she is pregnant, which is why supplementation is recommended for all women of childbearing age.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Anemia: </strong>While folic acid can help in the prevention of certain types of anemia, such as megaloblastic anemia, it is not the primary preventive measure for anemia during pregnancy, which is more commonly addressed with iron supplementation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Preeclampsia: </strong>Preeclampsia is a pregnancy complication characterized by high blood pressure and damage to other organ systems. There is no strong evidence that folic acid supplementation alone can prevent preeclampsia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Gestational diabetes: </strong>Gestational diabetes is a type of diabetes that develops during pregnancy. Folic acid supplementation is not known to prevent gestational diabetes; its primary preventive role is in reducing the risk of neural tube defects.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folic acid supplementation before and during early pregnancy is essential to prevent neural tube defects in the developing fetus.</span></span></p>",
    "correct_choice_id": 221115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10421,
    "choices": [
      {
        "id": 41650,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
      },
      {
        "id": 41651,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      },
      {
        "id": 41652,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
      },
      {
        "id": 41653,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are true regarding cytomegalovirus (CMV) infection? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Neonates who are asymptomatic at birth have a lesser risk of later sequelae.</span></li><li><span style=\"font-size:12.0pt;\">20-40% are symptomatic at birth.</span></li><li><span style=\"font-size:12.0pt;\">In developing countries, the rate of transmission of CMV infection to the infant is more common from primary maternal infection than reactivation.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis by urine specimen at 4 weeks of age</span></li></ol>",
    "unique_key": "Q5703497",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507173,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is a common congenital infection, and understanding the nuances of its transmission, diagnosis, and clinical implications is important.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Congenital CMV Infection:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Transmission:&nbsp;</strong>Congenital CMV infection can occur from either primary maternal infection (which is when the mother is infected with CMV for the first time during pregnancy) or from reactivation of a prior CMV infection in the mother. The risk of transmission to the fetus is significantly higher in cases of primary maternal infection (around 30%) compared to reactivation (about 1-2%). In developing countries, the prevalence of CMV reactivation is higher, but primary infection remains the more significant source of transmission to the fetus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Asymptomatic vs. Symptomatic:&nbsp;</strong>The majority of neonates with congenital CMV are asymptomatic at birth, and these asymptomatic infants have a lower risk of developing long-term sequelae such as sensorineural hearing loss compared to those who are symptomatic at birth.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation:&nbsp;</strong>About 10% of neonates with congenital CMV infection are symptomatic at birth. Symptoms can include hepatosplenomegaly, petechial rash, jaundice, chorioretinitis, microcephaly, and thrombocytopenia. These symptoms are associated with a higher risk of long-term complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnosis:&nbsp;</strong>CMV infection can be diagnosed by detecting the virus in urine, saliva, or blood within the first three weeks of life. Diagnosis at four weeks, as mentioned in option 4, is less likely to be reliable because it may represent postnatal infection rather than congenital infection.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B (1, 2):&nbsp;</strong>The percentage of neonates symptomatic at birth is around 10%, not 20-40%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C (2, 4):&nbsp;</strong>The diagnosis by urine specimen at four weeks is not ideal, and the percentage of symptomatic neonates at birth is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neonates who are asymptomatic at birth from congenital CMV infection have a lower risk of long-term sequelae, and transmission is more common from primary maternal infection than from reactivation, especially in developing countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-155140.png\" alt=\"\" width=\"400\" height=\"188\"></span></p>",
    "correct_choice_id": 41653,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20353,
    "choices": [
      {
        "id": 81373,
        "text": "<p><span style=\"font-size:18px;\">Aflatoxin</span></p>"
      },
      {
        "id": 81374,
        "text": "<p><span style=\"font-size:18px;\">Beta-oxalyl-amino-alanine</span></p>"
      },
      {
        "id": 81375,
        "text": "<p><span style=\"font-size:18px;\">Ergot alkaloids</span></p>"
      },
      {
        "id": 81376,
        "text": "<p><span style=\"font-size:18px;\">Fusarium toxin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A poor farmer with a history of successive crop failure develops progressive spastic paraparesis, signs of upper motor neuron paralysis, and gait instability. Name the toxin responsible for this condition. </strong><i><strong>[NEET PG &nbsp;2023]</strong></i></span></p>",
    "unique_key": "Q7406975",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507142,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Beta-oxalyl-amino-alanine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Given clinical scenario points to a diagnosis of neurolathyrism, for which the toxin responsible is beta-oxalyl-amino-alanine (BOAA).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Lathyrism is of two types:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Neurolathyrism: In human beings</span></li><li><span style=\"font-size:18px;\">Osteolathyrism: In animals</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Neurolathyrism is caused by eating the pulse \u2018Khesari Dal (Lathyrus sativus)\u2019. Diets containing over 30% of this dal consumed over a period of 2 - 6 months result in neurolathyrism</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Lathyrism affects 15 - 45 years of age</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Toxin: present in lathyrus seeds is \u2018Beta oxalyl amino alanine (BOAA)\u2019Q</span></li><li><span style=\"font-size:18px;\">It manifests as following stages:</span><ul><li><span style=\"font-size:18px;\">Latent stage</span></li><li><span style=\"font-size:18px;\">No-stick stage</span></li><li><span style=\"font-size:18px;\">One-stick stage</span></li><li><span style=\"font-size:18px;\">Two-stick stage</span></li><li><span style=\"font-size:18px;\">Crawler stage</span></li></ul></li><li><span style=\"font-size:18px;\">Interventions for prevention and control of Lathyrism:</span><ul><li><span style=\"font-size:18px;\">Vitamin C</span></li><li><span style=\"font-size:18px;\">Banning the crop</span></li><li><span style=\"font-size:18px;\">Removal of toxin: Steeping method and Parboiling</span></li><li><span style=\"font-size:18px;\">Education</span></li><li><span style=\"font-size:18px;\">Genetic approach</span></li><li><span style=\"font-size:18px;\">Socio-economic changes</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Aflatoxin:&nbsp;</strong>Toxin produced by Aspergillus species. It causes aflatoxicosis and is commonly found in contaminated ground nuts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Ergot alkaloids:&nbsp;</strong>Toxins produced by Claviceps species, leading to ergotism. Found in contaminated cereals.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Fusarium toxin:&nbsp;</strong>Toxins produced by Fusarium species, which can contaminate grains and other food products, causing fusarium toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Food Adulteration Diseases</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100324.png\" alt=\"\" width=\"1000\" height=\"417\"></span></p>",
    "correct_choice_id": 81374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54930,
    "choices": [
      {
        "id": 219181,
        "text": "<p><span style=\"font-size:12.0pt;\">185.5</span></p>"
      },
      {
        "id": 219182,
        "text": "<p><span style=\"font-size:12.0pt;\">189.5</span></p>"
      },
      {
        "id": 219183,
        "text": "<p><span style=\"font-size:12.0pt;\">192.5</span></p>"
      },
      {
        "id": 219184,
        "text": "<p><span style=\"font-size:12.0pt;\">195.5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Calculate the mid parental height of a male patient with father height 183 cm and mother height 175 cm?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">FMGE JULY 2024)</span></p>",
    "unique_key": "Q4018473",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507168,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) 185.5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mid-parental height (MPH) is a method used to estimate the potential adult height of a child based on the heights of the parents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Formula:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/screenshot-2024-08-27-181950.png\" alt=\"\" width=\"900\" height=\"266\"></p><p><span style=\"font-size:12.0pt;\">Using the given heights:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Father's height = 183 cm</span></li><li><span style=\"font-size:12.0pt;\">Mother's height = 175 cm</span></li><li><span style=\"font-size:12.0pt;\">MPH = [(183+175)/2] + 6.5 = 185.5</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the mid-parental height is 185.5 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To calculate the mid-parental height for a male child, use the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(Father\u2019s&nbsp;height+Mother\u2019s&nbsp;height)/2+6.5&nbsp;cm.</span></p>",
    "correct_choice_id": 219181,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6533,
    "choices": [
      {
        "id": 26101,
        "text": "<p><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
      },
      {
        "id": 26102,
        "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
      },
      {
        "id": 26103,
        "text": "<p><span style=\"font-size:12.0pt;\">Bempedoic acid</span></p>"
      },
      {
        "id": 26104,
        "text": "<p><span style=\"font-size:12.0pt;\">Clofibrate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a PCSK9 inhibitor?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
    "unique_key": "Q2992308",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507144,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Evolocumab</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alirocumab and Evolocumab are PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. These works by inhibiting the PCSK9 enzyme which is responsible for degradation of LDL receptors in the liver. Therefore, these drugs lead to an increased number of low-density lipoprotein (LDL) receptors on liver cells and a subsequent decrease in LDL cholesterol levels in the blood. PCSK9 inhibitors are used for lowering cholesterol levels, particularly in patients with familial hypercholesterolemia or those who are at high risk for cardiovascular disease and have not adequately responded to statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ezetimibe</strong>: Ezetimibe works by inhibiting the absorption of cholesterol in the small intestine, which leads to a reduction in the total amount of cholesterol presented to the liver. It does not inhibit PCSK9.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bempedoic Acid</strong>: Bempedoic acid is a relatively new cholesterol-lowering medication. It inhibits ATP citrate lyase, an enzyme involved in cholesterol synthesis, but it is not a PCSK9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Clofibrate</strong>: Clofibrate is a fibrate used to lower lipid levels, particularly triglycerides. It works by activating peroxisome proliferator-activated receptors (PPARs) and does not inhibit PCSK9.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a PCSK9 inhibitor that works by blocking the PCSK9 enzyme, leading to increased LDL receptor availability on liver cells and reduced LDL cholesterol levels in the blood.</span></p>",
    "correct_choice_id": 26101,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55999,
    "choices": [
      {
        "id": 223425,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blocks adenosine action and causes wakefulness</span></span></span></p>"
      },
      {
        "id": 223426,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activates locus coeruleus and cause wakefulness</span></span></span></p>"
      },
      {
        "id": 223427,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No role in maintaining wakefulness if taken 1hr before sleep</span></span></span></p>"
      },
      {
        "id": 223428,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activates histamine release and prevents sleep</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A man habitually consumes coffee before bedtime and claims difficulty in sleep during night. What is the role of caffeine in wakefulness?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q8351368",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507163,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Blocks adenosine action and causes wakefulness</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caffeine is a stimulant that is commonly consumed to reduce fatigue and increase alertness. Its primary mechanism of action in promoting wakefulness is through blocking the action of adenosine, a neurotransmitter in the brain that promotes sleep and relaxation by binding to adenosine receptors. Normally, when adenosine binds to its receptors, it leads to drowsiness and a decrease in nerve cell activity. Caffeine, due to its structural similarity to adenosine, competes for these receptors but does not activate them. Instead, it blocks the action of adenosine, preventing the onset of sleepiness and promoting wakefulness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Activates locus coeruleus and causes wakefulness:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The locus coeruleus is a nucleus in the brainstem involved in physiological responses to stress and panic, and it is active during REM sleep to help regulate wakefulness. However, caffeine does not directly activate the locus coeruleus to cause wakefulness; instead, its wakefulness-promoting effect is primarily through adenosine receptor blockade.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. No role in maintaining wakefulness if taken 1hr before sleep:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This statement is incorrect because caffeine does play a significant role in maintaining wakefulness even if consumed an hour before sleep. Caffeine has a half-life of about 5-6 hours, meaning it remains active in the system for several hours after consumption, potentially leading to difficulty falling asleep.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Activates histamine release and prevents sleep:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Histamine is a neurotransmitter involved in wakefulness, but caffeine does not exert its wakefulness-promoting effects through histamine release. The primary mechanism is through blocking adenosine receptors, not activating histamine release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caffeine promotes wakefulness primarily by blocking adenosine receptors in the brain, thereby preventing the sleep-inducing effects of adenosine.</span></span></span></p>",
    "correct_choice_id": 223425,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57150,
    "choices": [
      {
        "id": 227989,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV</span></span></span></p>"
      },
      {
        "id": 227990,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EBV</span></span></span></p>"
      },
      {
        "id": 227991,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HBV</span></span></span></p>"
      },
      {
        "id": 227992,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient of sickle cell anemia developed aplastic crisis after a viral infection. The agent causing it is: (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q5433403",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507147,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Parvovirus B19</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19 is known for its predilection for erythroid progenitor cells in the bone marrow, which it infects and destroys. This leads to a transient halt in red blood cell production, which can precipitate an aplastic crisis, particularly in patients with underlying hemolytic disorders like sickle cell anemia. The virus effectively shuts down erythropoiesis (red blood cell production), causing a significant drop in hemoglobin levels and resulting in severe anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Patients with sickle cell anemia are particularly susceptible to this type of crisis because they already have a high rate of red blood cell turnover due to the intrinsic hemolysis caused by their abnormal hemoglobin. When Parvovirus B19 infection superimposes on this condition, the cessation of red cell production can lead to a profound aplastic crisis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. CMV (Cytomegalovirus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CMV is a type of herpesvirus that can cause various infections, especially in immunocompromised individuals, but it is not known to specifically cause aplastic crises or target red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. EBV (Epstein-Barr Virus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> EBV is associated with infectious mononucleosis and can affect the lymphoid tissue but does not directly cause aplastic crisis by targeting red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. HBV (Hepatitis B Virus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> HBV primarily affects the liver, causing hepatitis, and does not have a known mechanism of inducing aplastic crisis by directly affecting the bone marrow&#39;s red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19 is the primary viral agent responsible for causing aplastic crisis in patients with sickle cell anemia due to its affinity for and destruction of erythroid progenitor cells in the bone marrow.</span></span></span></p>",
    "correct_choice_id": 227992,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24777,
    "choices": [
      {
        "id": 99069,
        "text": "<p><span style=\"font-size:11.0pt;\">Centromeric</span></p>"
      },
      {
        "id": 99070,
        "text": "<p><span style=\"font-size:11.0pt;\">Homogenous</span></p>"
      },
      {
        "id": 99071,
        "text": "<p><span style=\"font-size:11.0pt;\">Speckled</span></p>"
      },
      {
        "id": 99072,
        "text": "<p><span style=\"font-size:11.0pt;\">Nucleolar</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the type of ANA staining pattern shown in the image below? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152907.png\" alt=\"\" width=\"300\" height=\"294\"></span></p>",
    "unique_key": "Q9858959",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507145,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Centromeric</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The centromeric pattern is characterized by distinct dots in the nucleus, corresponding to centromeres during cell division. This pattern is associated with <strong>anti-centromere antibodies (ACA)</strong>, commonly seen in limited cutaneous scleroderma (CREST syndrome). ACA antibody&nbsp;is&nbsp; correlate with pulmonary hypertension seen in patients with limited disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Homogenous:</strong> Diffuse staining of the nucleus, seen with anti-ds DNA antibodies or anti-histone antibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Speckled</strong>: Numerous fine or coarse speckles, a kind of quite nonspecific, associated with various antibodies such as anti-SEL70, anti-JOAN, and anti-SMITH antibodies, etc</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nucleolar</strong>: Prominent nucleolar staining, quite nonspecific, seen with Anti-PM-Scl antibody, an overlap antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Centromeric pattern in ANA staining is associated with anti-centromere antibodies and limited scleroderma.</span></p>",
    "correct_choice_id": 99069,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14924,
    "choices": [
      {
        "id": 59656,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium and vitamin D</span></p>"
      },
      {
        "id": 59657,
        "text": "<p><span style=\"font-size:12.0pt;\">Hormone replacement therapy</span></p>"
      },
      {
        "id": 59658,
        "text": "<p><span style=\"font-size:12.0pt;\">Alendronate</span></p>"
      },
      {
        "id": 59659,
        "text": "<p><span style=\"font-size:12.0pt;\">Repeat DEXA scan after 6 months</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old postmenopausal woman comes with a history of Colles\u2019 fracture 6 months ago. Her DEXA scan reveals T score of -2.5. What is the next best step?(INICET NOV 2021)</span></p>",
    "unique_key": "Q3440283",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507140,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Alendronate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOPOROSIS (V &gt; H &gt; C)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osteoporosis is <strong>reduction in bone mass (density)</strong> i.e., there is <strong>quantitative decrease of units of bone formation</strong> but each unit has qualitatively normal configuration.</span></li><li><span style=\"font-size:12.0pt;\">Bone mineral density is measured by DEXA scan (65 years onwards).</span></li><li><span style=\"font-size:12.0pt;\">Normal Ca<sup>2+</sup>, PO<sup>\u2011</sup><sub>4</sub>, ALP</span></li><li><span style=\"font-size:12.0pt;\">Hemiplegic \u2013 Humerus maximum loss of bone mineral density.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_99.jpg\" alt=\"\" width=\"1000\" height=\"400\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Etiology:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-02-192803.jpg\" alt=\"\" width=\"1000\" height=\"365\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Radiological Investigation:</strong></span><span style=\"font-size:11pt;\">&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Quantitative CT is a newer imaging technique that can be used to detect osteoporosis.</span></li><li><span style=\"font-size:12.0pt;\">Radiological features are <strong>loss of vertical height of vertebrae</strong> (collapse) and <strong>codfish appearance </strong>(concave superior and inferior surfaces) of vertebrae</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture20.jpg\" alt=\"\" width=\"250\" height=\"356\"></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Singh\u2019s Index</strong> is used for osteoporosis grading.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ol><li><span style=\"font-size:12.0pt;\"><strong>Inhibit resorption:</strong> Bisphosphonates (drug of choice), Denosumab, calcitonin, estrogen, SERMS, gallium nitrate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stimulate formation:</strong> Teriparatide (PTH analogue), calcium, calcitriol, fluorides.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Both actions:</strong> Strontium ranelate</span><br>&nbsp;</li></ol></li><li><span style=\"font-size:12.0pt;\"><strong>Alendronate:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Alendronate is approved for the treatment of postmenopausal osteoporosis,&nbsp;steroid-induced osteoporosis, and male osteoporosis.</span></li><li><span style=\"font-size:12.0pt;\">Alendronate belongs to&nbsp;the class of bisphosphonate medications, which aids in the prevention of bone resorption and the promotion of bone density, making it a valuable treatment for osteoporosis.</span></li><li><span style=\"font-size:12.0pt;\">Alendronate is an option for maintaining or increasing bone mass, whereas risedronate is preferred in men with osteoporosis.</span></li><li><span style=\"font-size:12.0pt;\">It inhibit bone resorption at rates 1000 times greater than the effect on bone formation.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcium and Vitamin D.&nbsp;</strong>They are given along with the bisphosphonates but are not the only treatment choice.<strong> </strong>Calcium is given at a dose of 1500 mg/day. Vitamin D is given at the dose of 400-800 IU per day. Initially, Vit. D deficient patients are treated with active metabolite 1,25, dihydroxy Vit D3 (short half-life 4 hours and expensive) then changing over to longer lasting and less expensive Vit D2 or D3 (t \u00bd up to 2\u00bd months).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hormone replacement therapy.&nbsp;</strong>The mainstay of bone loss prevention in postmenopausal osteoporosis&nbsp;is estrogen treatment. Daily dose of 0.625 mg of conjugated estrogen in combination with progestins are recommended. Progestin is essential (even though it has no independent effect on bone) to reduce the risk of developing endometrial cancer (due to estrogen).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Repeat DEXA scan after 6 months</strong>. The DEXA scan is repeated after 6 months to 1 year after starting of the drug treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alendronate, a drug of class of bisphosphonates is the drug of choice for the treatment of osteoporosis.</span></p>",
    "correct_choice_id": 59658,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13022,
    "choices": [
      {
        "id": 52050,
        "text": "<p><span style=\"font-size:12.0pt;\">Potassium permanganate</span></p>"
      },
      {
        "id": 52051,
        "text": "<p><span style=\"font-size:12.0pt;\">Arsenic</span></p>"
      },
      {
        "id": 52052,
        "text": "<p><span style=\"font-size:12.0pt;\">Thallium</span></p>"
      },
      {
        "id": 52053,
        "text": "<p><span style=\"font-size:12.0pt;\">Lead</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a village, the residents find a new groundwater source. After intake of water from this source many villagers presented with nausea, vomiting, dark bloody stools, conjunctivitis, and a burning sensation in the throat and stomach. Which poisoning do you suspect in this case? (</span>INICET Nov 2021)</p>",
    "unique_key": "Q2545042",
    "question_audio": null,
    "question_video": null,
    "map_id": 20507146,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Arsenic</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The given clinical scenario points towards arsenic poisoning</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Causes of arsenic poisoning: Arsenic poisoning occurs most often in major areas of agriculture and industrialization. It occurs through contaminated groundwater, air, soil or food.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Potassium permanganate:&nbsp;</strong>Typically causes caustic injuries, including severe mucosal burns upon ingestion, but not the full range of symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thallium:&nbsp;</strong>Causes symptoms such as gastrointestinal distress, neurological symptoms, and hair loss, but does not match the full clinical picture described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lead:&nbsp;</strong>Lead poisoning causes anemia, abdominal pain, neurological symptoms, and kidney damage, but does not match the described symptoms of conjunctivitis and burning sensation in the throat and stomach.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-34.jpg\" alt=\"\" width=\"500\" height=\"280\"></span></p>",
    "correct_choice_id": 52051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00121 Mid Day Module (Pyqs, Mixed Bag-18)';
        const quizFilename = '00121-mid-day-module-pyqs-mixed-bag-18-406d03bd.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>